tert-Butyl 4-(5-bromo-2-nitrophenyl)piperazine-1-carboxylate

Catalog No.: 
ACBFNB810
CAS No.: 
1779120-39-6
Molecular Formula: 
C15H20BrN3O4
Molecular Weight: 
386.25
tert-Butyl 4-(5-bromo-2-nitrophenyl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$3686.001 week1 week

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(5-bromo-2-nitrophenyl)piperazine-1-carboxylate
IUPAC Nametert-butyl 4-(5-bromo-2-nitrophenyl)piperazine-1-carboxylate
Molecular FormulaC15H20BrN3O4
Molecular Weight386.25
SMILESO=C(N1CCN(C2=CC(Br)=CC=C2[N+]([O-])=O)CC1)OC(C)(C)C
InChI KeyJSGZAIHGGGIKJP-UHFFFAOYSA-N
Synonymtert-Butyl 4-(5-bromo-2-nitrophenyl)-piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-(5-bromo-2-nitrophenyl)-, 1,1-dimethylethyl ester
CAS No.1779120-39-6

Synthetic Route by SureRoute

1. ACBFNB810 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7In Stock
  2. Plus
  3. ACPGWX307 route compound structure diagram
    ACPGWX307321-23-3In Stock
  4. Then
  5. ACBFNB810 route product structure diagram
    ACBFNB8101779120-39-6
Inquiry

2. ACBFNB810 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7In Stock
  2. Plus
  3. ACOJBZ257 route compound structure diagram
    ACOJBZ25789465-97-4In Stock
  4. Then
  5. ACBFNB810 route product structure diagram
    ACBFNB8101779120-39-6
Inquiry

3. ACBFNB810 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7In Stock
  2. Plus
  3. ACYVZA174 route compound structure diagram
    ACYVZA17451686-78-3In Stock
  4. Then
  5. ACBFNB810 route product structure diagram
    ACBFNB8101779120-39-6
Inquiry

Comments (0)